News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PLx Pharma Inc. Files New Drug Application With FDA and Adds New Board Member


5/23/2012 11:35:40 AM

HOUSTON--(BUSINESS WIRE)--PLx Pharma Inc., a specialty pharmaceutical company developing a novel aspirin and lipid complex (PL2200 Aspirin 325 mg), reports that the United States Food and Drug Administration (FDA) has accepted for review a new drug application (NDA) for PL2200 Aspirin 325 mg, and the company has elected Peter Mann to its Board of Directors.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES